Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 12/2006

01-12-2006 | Case report

A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

Authors: Chiaki Okuse, Kayo Adachi, Yoshiki Katakura, Kotaro Matsunaga, Toshiya Ishii, Nobuyuki Matsumoto, Hiroshi Yotsuyanagi, Shiro Iino, Michihiro Suzuki, Fumio Itoh

Published in: Journal of Gastroenterology | Issue 12/2006

Login to get access
Metadata
Title
A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C
Authors
Chiaki Okuse
Kayo Adachi
Yoshiki Katakura
Kotaro Matsunaga
Toshiya Ishii
Nobuyuki Matsumoto
Hiroshi Yotsuyanagi
Shiro Iino
Michihiro Suzuki
Fumio Itoh
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 12/2006
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-006-1910-2

Other articles of this Issue 12/2006

Journal of Gastroenterology 12/2006 Go to the issue

Letters to the editor

Transnasal ERCP/ENBD using an ultrathin esophagogastroduodenoscope

OriginalPaper

Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis

OriginalPaper

Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais

OriginalPaper

Extracellular signal-regulated kinase 1- and 2-mediated gastric mucosal injury and repair in gastric ischemia–reperfusion of rats

OriginalPaper

Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line

OriginalPaper

Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits